MiMedx Group, Inc. Accrued Liabilities for Commissions, Expense and Taxes
MiMedx Group, Inc. (MDXG) had Accrued Liabilities for Commissions, Expense and Taxes of $1.47 million as of 2012-12-31, per its 10-K filed 2013-03-15.
Discontinued › Notes
us-gaap:AccruedLiabilitiesForCommissionsExpenseAndTaxes · last filed 2013-03-15
- 2012-12-31: Accrued Liabilities for Commissions, Expense and Taxes $1.47M.
- 2011-12-31: Accrued Liabilities for Commissions, Expense and Taxes $112.91K.
| Period end | Accrued Liabilities for Commissions, Expense and Taxes |
|---|---|
| 2012-12-31 | $1.47M 10-K · filed 2013-03-15 |
| 2011-12-31 | $112.91K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |